Basics of US patents and the patent system

AAPS Journal

Volumn 9, Issue 3, 2007, Pages

  Elliott, George ^a  

^a United States Patent and Trademark Office   (United States)

Author keywords

Biotechnology; Description; Examiner; Obviousness; Patent; Pharmaceutical; Utility

Indexed keywords

DRUG;

ARTICLE; BIOTECHNOLOGY; DECISION MAKING; DRUG INDUSTRY; DRUG RESEARCH; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HUMAN; INFORMATION DISSEMINATION; LEGAL ASPECT; MEDICAL RESEARCH; PATENT; PRODUCT DEVELOPMENT; QUALITY OF LIFE; UNITED STATES;

BIOTECHNOLOGY; HUMANS; PATENTS; PHARMACEUTICAL SERVICES; QUALITY OF LIFE; UNITED STATES;

EID: 35248852547     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj0903035     Document Type: Article

References (7)

1. Utility Examination Guidelines. 66 Federal Register 1092 (2001). Available at: http://www.uspto.gov/web/offices/com/sol/notices/ utilexmguide.pdf. Accessed July 14, 2007.
2. Brenner v Manson, 383 US 519, 148 USPQ 689 (1966).
3. In re Fisher, Court of Appeals for the Federal Circuit, 421 F3d 1365, 76 USPQ2d 1225 (Fed Cir 2005).
4. Graham v John Deere, 383 US 1, 148 USPQ 459 (1966).
5. KSR International Co v Teleflex Inc et al, 127 SCt 1727 (2007).
6. Bell, In re, 991 F2d 781, 26 USPQ2d 1529 (Fed Cir 1993).
7. Deuel, In re, 51 F3d 1552, 34 USPQ2d 1210 (Fed Cir 1995).